A Ryan

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi Ensuring the quality of quality of life data: the Southwest Oncology Group experience
    C M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98104, USA
    Stat Med 17:641-51. 1998
  2. ncbi Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors
    C M Moinpour
    Southwest Oncology Group Statistical Center, Division of Public Health Sciences, and Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Clin Oncol 18:1942-53. 2000
  3. ncbi Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial
    C M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Psychooncology 9:340-54. 2000
  4. ncbi Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases
    C M Moinpour
    Southwest Oncology Group Statistical Center, Seattle, WA, USA
    Qual Life Res 9:219-31. 2000
  5. ncbi Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial
    C M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Qual Life Res 11:115-26. 2002
  6. ncbi A systematic review and economic evaluation of statins for the prevention of coronary events
    S Ward
    School of Health and Related Research ScHARR, University of Sheffield, UK
    Health Technol Assess 11:1-160, iii-iv. 2007
  7. ncbi The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation
    D Hind
    School of Health and Related Research, University of Sheffield, UK
    Health Technol Assess 12:iii-ix, xi-162. 2008

Collaborators

  • P A Ganz
  • S A Shumaker
  • F M Muggia
  • J E Ware
  • D R Gandara
  • P Tappenden
  • W Yeo
  • R M Ara
  • K Kelly
  • C M Moinpour
  • L C Lovato
  • D Hind
  • S Ward
  • B Lyons
  • I Tumur
  • S Eggington
  • P Sutcliffe
  • M Holmes
  • M Lloyd Jones
  • A Pandor
  • N Payne
  • Z M Buckner
  • J Crowley
  • P K Grevstad
  • K Czaplicki
  • L Tanaka
  • I M Thompson
  • S P Schmidt
  • W A James
  • M Lennard
  • F L Meyskens
  • B McKnight
  • C G Leichman
  • C A Coltman
  • D L Patrick
  • K Chansky
  • G W Donaldson
  • C Upchurch
  • J Sawyers Triplett
  • R A Patchell

Detail Information

Publications7

  1. ncbi Ensuring the quality of quality of life data: the Southwest Oncology Group experience
    C M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98104, USA
    Stat Med 17:641-51. 1998
    ....
  2. ncbi Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors
    C M Moinpour
    Southwest Oncology Group Statistical Center, Division of Public Health Sciences, and Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Clin Oncol 18:1942-53. 2000
    ..To describe men who agreed to be randomized to the Prostate Cancer Prevention Trial (PCPT), a 7-year, double-blind placebo-controlled study of the efficacy of finasteride in preventing prostate cancer...
  3. ncbi Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial
    C M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Psychooncology 9:340-54. 2000
    ..This problem appears to be particularly challenging in the context of advanced-stage disease. Failure to recognize the presence of non-random missing data can lead to serious overestimates of patient QOL over time...
  4. ncbi Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases
    C M Moinpour
    Southwest Oncology Group Statistical Center, Seattle, WA, USA
    Qual Life Res 9:219-31. 2000
    ..A longitudinal analysis suggests that the use of proxy rather than patient responses could lead to different conclusions concerning radiation therapy's effect on QOL...
  5. ncbi Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial
    C M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Qual Life Res 11:115-26. 2002
    ..A second purpose of this paper is to examine methods for handling the level of missing data commonly observed in the advanced stage disease context...
  6. ncbi A systematic review and economic evaluation of statins for the prevention of coronary events
    S Ward
    School of Health and Related Research ScHARR, University of Sheffield, UK
    Health Technol Assess 11:1-160, iii-iv. 2007
    ..To evaluate the clinical effectiveness and cost-effectiveness of statins for the primary and secondary prevention of cardiovascular events in adults with, or at risk of, coronary heart disease (CHD)...
  7. ncbi The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation
    D Hind
    School of Health and Related Research, University of Sheffield, UK
    Health Technol Assess 12:iii-ix, xi-162. 2008
    ..To examine the role of irinotecan and oxaliplatin in reducing the extent of incurable disease before curative surgery (downstaging)...